Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	627.21	-1102.39	151.59
Graham Fair Price	177.30	54.87	19.79
PEG	-98.03	0.01	-0.54
Price/Book	-4.71	2.08	2.18
Price/Cash Flow	0.10	57.68	57.63
Prices/Earnings	-85.45	6.52	44.78
Price/Sales	-29.12	9.01	12.71
Price/FCF	0.10	57.68	57.63
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	357.09	0.41	0.09
ROA	636.66	0.02	< 0.005
ROE	0.01	0.08	554.89
ROIC	0.01	0.06	473.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.06	20.92
Dividends QOQ	< 0.005	0.19	5642.27
EBIT QOQ	-0.81	5.58	585.93
EPS QOQ	-0.83	6.11	639.18
FCF QOQ	-0.34	0.02	-94.42
Revenue QOQ	-0.24	0.44	85.36
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	20.21	17.19	-14.95
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.25	0.25	-0.09
Quick Ratio	2.98	1.72	-42.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.78	40.94	8.36
Cash	9.87	11.12	12.56
Capex	0.00	0.00	0.00
Free Cash Flow	1.43	1.48	3.16
Revenue	6.49	9.46	45.67
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.31	1.88	-43.14
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.15	-60.38	560.26
Naive Interpretation	Member

06 - Financial Health · Weak

Rating